tions, we observed a decrease in IP 7 cellular concentrations in response to phosphate starvation (A.S., unpublished data) , suggesting that more characterization of this response may be necessary.
Lee et al. convincingly provide a link between Vip1-mediated inositol pyrophosphate signaling and phosphate metabolism. However, previous reports have also linked Kcs1 and its IP6K family members to phosphate metabolism, suggesting that both 5PP-IP 5 and 4/6PP-IP 5 have roles in these processes. Indeed, the first clue to a relationship between inositol pyrophosphate signaling and phosphate metabolism came from the discovery that PiUS, a stimulator of inorganic phosphate uptake, was in fact IP6K2 (Bennett et al., 2006 The beneficial effects of vitamin A might have been recognized first by the ancient Egyptians, who treated eye disease with raw liver. The fact that they recognized a connection between eye problems and the liver, which is the richest source of dietary vitamin A, is astonishing. Today, we know that vitamin A (retinol) and its biologically active derivatives, the retinoids (the most potent of which is all-trans-retinoic acid), regulate key processes such as inhibition of cell proliferation, differentiation, apoptosis, shaping of the embryo, Retinoic acid-the active metabolite of vitamin A-influences biological processes by activating the retinoic acid receptor (RAR). In this issue, Schug et al. (2007) demonstrate that retinoic acid also activates the peroxisome proliferator-activated receptor β/δ (PPARβ/δ). Remarkably, retinoic acid signaling through RAR or PPARβ/δ-which depends on cytoplasmic retinoic acid transporters-commits the cell to opposite fates, apoptosis or survival, respectively. and organogenesis. Vitamin A deficiency causes congenital malformations of the eye, heart, gonads, and lungs. In both youths and adults, lack of vitamin A impairs growth, vision, reproduction, and homeostasis of several organs (Mark et al., 2006) . Active metabolites of vitamin A can prevent and cure a majority of these defects. In addition, retinoids have anticancer properties, as illustrated by their efficacy in the treatment of promyelocytic leukemia.
Guiding Ligands to nuclear Receptors
A long-standing question has been how a simple molecule like all-trans-retinoic acid (RA) exerts pleiotropic actions.
In an elegant study presented in this issue, Noy and colleagues (Schug et al., 2007) provide a new and unexpected answer to this question. These authors reveal that RA can signal through two nuclear hormone receptors, the retinoic acid receptor (RAR) and the peroxisome proliferator-activated receptor β/δ (PPARβ/δ), leading to opposite outcomes for the cells expressing these receptors: apoptosis and survival, respectively (Figure 1 ).
To date, only one type of nuclear receptor, RAR (α, β, and γ), was thought to bind to both RA and 9-cisretinoic acid (Germain et al., 2006) . RARs form heterodimers with retinoid X receptors (RXRs) α, β, or γ, which only bind to 9-cis-retinoic acid. RAR-RXR heterodimers regulate gene expression through molecular mechanisms involving a large number of coregulators (Glass and Rosenfeld, 2000) . The interplay of these actors establishes a gradient of gene activity ranging from repression to full activation. As each component of this machinery is itself under specific transcriptional and posttranscriptional control, a diversity of responses is possible.
During their transport in the aqueous intracellular milieu, many hydrophobic ligands including retinoids are solubilized and stabilized by binding to proteins that participate in mediating their biological activities. Two such proteins, CRABP-I and CRABP-II, have a high affinity for RA. CRABP-I is thought to dampen the cellular responses to RA by promoting its degradation, whereas CRABP-II delivers RA to RAR. This activity is mediated by a protein-protein interaction between CRABP-II and RAR, resulting in a direct transport of the ligand to the receptor (Dong et al., 1999) .
Both RA-binding proteins belong to an evolutionarily conserved family, which also includes nine fatty acidbinding proteins (FABPs) (Chmurzynska, 2006) . Some of the latter are known to deliver ligands to the PPARs. For instance, specific interactions with keratinocyte FABP (FABP5) and adipocyte FABP (FABP4) selectively enhance the activity of PPARβ/δ and PPARγ, respectively. Interestingly, these FABPs relocate to the nucleus when bound to ligands that are selective for the PPAR isotype they activate. Thus, these FABPs control the transcriptional activities of their own ligands, which they transport to cognate PPARs in the nucleus . Interestingly, PPARs belong to the same type 2 class of receptors as RARs in the nuclear receptor superfamily (Michalik et al., 2006) . Together, these findings suggest a coevolution of the fatty-acid-and retinoid-binding protein families in parallel with the RAR and PPAR families, which enabled the emergence of a system for directing a ligand to the appropriate receptor. An interesting question is whether the two associated systems, CRABPs-RAR and FABPsPPARs, have completely tight modes of action or if some promiscuity remains at the expense of specificity but in favor of an increased diversity in responses.
The work of Schug et al. (2007) provides a first answer to this interrogation. RA usually displays anticarcinogenic, proapoptotic activity. The authors were intrigued by an effect of RA in promoting cell survival in some organs, such as skin, in an RAR-independent manner (Chapellier et al., 2002) and in a way that is reminiscent of PPARβ/δ activity (Di-Poi et al., 2002) . They hypothesized that RA can control a repertoire of cellular responses that involves either RAR or PPARβ/δ. They found that-depending on the ratio of FABP5 to CRABP-II-RA activates RAR or PPARβ/δ. In mammary carcinoma MCF-7 cells and in keratinocytes, which express a low and high FABP5 to CRABP-II ratio, respectively, RA activates RAR in the former and PPARβ/δ in the latter. Thus, the surprising finding is that when the FABP5 to CRABP-II ratio is high, RA serves as a physiological ligand for PPARβ/δ. This directed transport of RA to PPARβ/δ broadens the spectrum of physiological regufigure 1. Retinoic Acid Activates RAR and PPARβ/δ Vitamin A is internalized by the cell and metabolized into its active derivative, retinoic acid (RA). In the aqueous intracellular milieu, RA is transported by the retinoid-binding protein CRABP-II, or by the fatty-acid-binding protein FABP5, depending on the ratio of FABP5 to CRABP-II. In a cell type expressing high CRABP-II and low FABP5, RA activates the retinoic acid receptor (RAR), whereas in the presence of the reverse ratio (low CRABP-II and high FABP5), RA activates the peroxisome proliferator-activated receptor β/δ (PPAR). This leads to opposite cellular outcomes: either apoptosis, growth arrest, and anticancer activity or survival, proliferation, and tumor growth, respectively. In both situations, retinoid X receptor (RXR) is the indispensable dimerization partner of the nuclear receptor involved.
lation of the receptor's activity in an unexpected way, and it sheds new light on RA as an antiapoptotic agent and on PPARβ/δ as an RA receptor. This raises numerous new questions. Does RA exert antiapoptotic, proproliferative effects in tumors other than the mammary cancer model used by Schug et al. (2007) ? Are some developmental processes, which are controlled by RA, dependent on directed transport of RA to PPARβ/δ? Can the switch from proliferation to differentiation observed in organ development be a consequence of ligand preference for one receptor over the other? PPARβ/δ, in addition to cell-survival functions, also participates in metabolic regulation under the control of fatty-acid ligands. Does RA participate in these regulations under specific conditions?
In fact, the key issue raised by the work of Schug et al. (2007) concerns the importance of directed ligand transport in nuclear receptor activation and ligand-dependent crosstalk between different receptor types. Breaking barriers between receptor categories by this mechanism may not be unique to RAR and PPARβ/δ. Promiscuity induced by directed ligand transport may participate significantly in the astonishing pleiotropic effects of key members of the nuclear receptor superfamily.
